Large-scale testing (Phase 3)WithdrawnNCT04361552
What this trial is testing
Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)
Who this might be right for
Cerebrovascular AccidentChronic Obstructive Pulmonary DiseaseChronic Renal Failure+4 more
Emory University